Want to see G full AI Analyst Report?
Top Page
Genpact
(NYSE:G)
Select Model
Select Model
Rating:71Outperform
Price Target:
$41.00
▲(31.16% Upside)
Action:Reiterated
Date:05/09/26
The score is supported by solid financials (improved leverage, strong returns, and healthy profitability) and an attractive valuation (low P/E with a ~2.1% yield), plus constructive FY2026 guidance and ATS momentum. These positives are meaningfully offset by weak technicals, with the stock trading well below key moving averages and bearish momentum despite oversold readings.
Positive Factors
Advanced Technology Solutions (ATS) growth
Sustained double-digit ATS growth and a rapidly expanding pipeline indicate a structural shift toward higher‑margin, technology‑led services. This durable revenue mix supports recurring, outcome-based contracts, improving revenue quality and establishing a platform for above‑market organic growth over the medium term.
Negative Factors
Slower legacy core growth
Stalled growth in legacy services creates a structural headwind as the firm transitions mix toward ATS. If new technology offerings do not scale fast enough, overall top‑line expansion could underperform, pressuring resource reallocation and near‑term revenue stability during the multi‑quarter transition.
Read all positive and negative factors
Positive Factors
Negative Factors
Advanced Technology Solutions (ATS) growth
Sustained double-digit ATS growth and a rapidly expanding pipeline indicate a structural shift toward higher‑margin, technology‑led services. This durable revenue mix supports recurring, outcome-based contracts, improving revenue quality and establishing a platform for above‑market organic growth over the medium term.
Read all positive factors
Genpact Key Performance Indicators (KPIs)
Any
Number of Clients Greater Than $25m Revenue
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Data provided by:
The Fly
The FlyGenpact (G) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.96B
Dividend Yield2.03%
Average Volume (3M)2.36M
Price to Earnings (P/E)10.7
Beta (1Y)0.71
Revenue Growth6.47%
EPS Growth10.82%
CountryUS
Employees145,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)3.30
Shares Outstanding169,506,520
10 Day Avg. Volume1,822,854
30 Day Avg. Volume2,355,690
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)3.19
Price to Sales (P/S)1.60
P/FCF Ratio11.07
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$37.88Price Target Upside21.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)4.07
Revenue Forecast (FY)$5.43B
Genpact Business Overview & Revenue Model
Company Description
Genpact Limited (G) is a global professional services firm specializing in business process management and information technology solutions. The company extends its offerings across diverse geographies, including India, the wider Asian market, Nor...
How the Company Makes Money
Genpact primarily makes money by delivering contracted services to enterprise clients, generating revenue from fees for (1) managed services/business process outsourcing (BPO) and operations work and (2) professional services such as consulting, t...
Genpact Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Aug 06, 2026
Earnings Call Sentiment Positive
The call presents a largely positive picture: accelerating high-value revenue in Advanced Technology Solutions (ATS) and agentic offerings, strong margin expansion, record backlog/pipeline, and meaningful partner and client wins outweigh measured near-term challenges such as slow growth in legacy core business services, early-stage realization of headcount decoupling, and macro/ execution risks tied to rapid adoption of new technologies.Positive Updates
Record start to fiscal year
Total revenue $1.296B, up 6.7% year-over-year; company reiterates full-year expectation of at least 7% growth (as-reported). Q2 revenue guidance $1.324B–$1.336B (~6% growth at midpoint).
Negative Updates
Slower growth in core business services
Core business services revenue $951M increased only 1.4% year-over-year, materially lagging ATS growth and reflecting an ongoing mix transition that may pressure near-term top-line growth in legacy offerings.
Read all updates
Q1-2026 Updates
Positive
Negative
Record start to fiscal year
Total revenue $1.296B, up 6.7% year-over-year; company reiterates full-year expectation of at least 7% growth (as-reported). Q2 revenue guidance $1.324B–$1.336B (~6% growth at midpoint).
Read all positive updates
Company Guidance
Genpact guided to at least 7% revenue growth for fiscal 2026 (as‑reported) with Advanced Technology Solutions now expected to grow at least 20% (Q1 ATS was $345M, +24% YoY and 27% of revenue); full‑year gross margin is expected to expand ~50 bps to 36.5% and adjusted operating income margin to increase ~25 bps to 17.7%, with adjusted diluted EPS forecast to grow over 10% (Q1 adjusted diluted EPS was $0.98, +16.7% YoY; Q1 total revenue $1.296B, +6.7%). For Q2 they expect revenue of $1.324–$1.336B (midpoint ≈6% YoY), ATS growth ≥20%, gross margin ~36.4%, adjusted operating income margin ~17.4%, and adjusted diluted EPS of $0.96–$0.97; management also cited record backlog, pipeline and inflows, six large deals in Q1, non‑FTE revenue at 48%, partner revenue up 35% to ~13% of total, $578M cash, and $102M returned to shareholders in Q1.Genpact Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
83
Very Positive
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.16B | 5.08B | 4.77B | 4.48B | 4.37B | 4.02B |
| Gross Profit | 1.88B | 1.81B | 1.69B | 1.57B | 1.54B | 1.43B |
| EBITDA | 873.46M | 874.70M | 852.58M | 772.52M | 652.86M | 709.01M |
| Net Income | 569.63M | 552.49M | 513.67M | 631.25M | 353.40M | 369.45M |
Balance Sheet | ||||||
| Total Assets | 5.62B | 5.84B | 4.99B | 4.81B | 4.59B | 4.98B |
| Cash, Cash Equivalents and Short-Term Investments | 928.08M | 1.20B | 671.61M | 583.67M | 646.76M | 899.46M |
| Total Debt | 1.76B | 1.76B | 1.45B | 1.50B | 1.70B | 2.00B |
| Total Liabilities | 3.14B | 3.29B | 2.60B | 2.56B | 2.76B | 3.08B |
| Stockholders Equity | 2.48B | 2.55B | 2.39B | 2.25B | 1.83B | 1.90B |
Cash Flow | ||||||
| Free Cash Flow | 658.83M | 734.65M | 530.19M | 432.04M | 389.28M | 637.03M |
| Operating Cash Flow | 748.88M | 812.86M | 615.42M | 490.81M | 443.67M | 694.28M |
| Investing Cash Flow | -527.72M | -495.50M | -105.96M | -78.94M | -36.59M | -122.75M |
| Financing Cash Flow | -185.60M | -106.81M | -424.85M | -483.00M | -571.40M | -332.88M |
Genpact Technical Analysis
Positive
31.26
Price Trends
30.97
Positive
33.15
Positive
37.85
Negative
Market Momentum
0.09
Negative
57.01
Neutral
55.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For G, the sentiment is Positive. The current price of 31.26 is below the 20-day moving average (MA) of 31.28, above the 50-day MA of 30.97, and below the 200-day MA of 37.85, indicating a neutral trend. The MACD of 0.09 indicates Negative momentum. The RSI at 57.01 is Neutral, neither overbought nor oversold. The STOCH value of 55.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for G.
Genpact Risk Analysis
Genpact disclosed 43 risk factors in its most recent earnings report. Genpact reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Genpact Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $5.14B | 21.34 | 28.49% | ― | 13.63% | 9.52% | |
71 Outperform | $5.96B | 10.66 | 22.44% | 2.29% | 6.47% | 10.82% | |
69 Neutral | $5.51B | 15.08 | 10.67% | ― | 14.21% | -2.92% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $2.99B | 15.84 | 16.40% | ― | 0.23% | -20.13% | |
54 Neutral | $1.82B | 14.79 | 3.97% | ― | -2.42% | -65.01% |
* Technology Sector Average
G
Genpact
35.17
-6.61
-15.81%
EPAM
Epam Systems
105.56
-47.74
-31.14%
EXLS
Exlservice Holdings
33.93
-8.64
-20.30%
DXC
DXC Technology
11.24
-2.10
-15.74%
KD
Kyndryl Holdings Incorporation
13.55
-23.15
-63.08%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.